Prism Venture Management

The firm was co-founded in 1996 by Bob Fleming and John Brooks, who led investment decisions for over two decades. John Brooks departed the firm in the mid-2010s to found Juggernaut Capital Partners, a growth-equity firm. Bob Fleming and other legacy partners continued to manage Prism's remaining portfolio, though the firm has not publicly detailed its current decision-making structure for follow-on investments.

Prism has not announced or filed for a new institutional fund since closing Prism Venture Partners V at $300 million in 2007 (per SEC filings). The firm currently operates in a portfolio-management and stewardship mode, focused on realizing value from legacy holdings rather than competing for new LP commitments.

Historically, Prism concentrated on digital health — including medical devices and health IT — and enterprise software and infrastructure. Representative portfolio companies include ConforMIS, a personalized knee-replacement manufacturer, and Veracode, an application-security platform acquired for $614 million. The firm also invested in communications-infrastructure companies such as Mavenir Systems.

Prism no longer appears to be actively originating new platform investments at scale. Its deal-sourcing historically relied on the Boston venture ecosystem and the partners' operating networks. In its current stewardship mode, sourcing is limited to follow-on capital for existing portfolio companies and opportunistic liquidity events.

Prism is a traditional venture capital firm, not a family office. It raised institutional capital from outside limited partners across five funds. However, since its last fund closed in 2007, its operational structure has shifted toward managing distributed portfolio assets — a posture similar to a fund in runoff — rather than actively marketing new vehicles.